Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Chinese Academy of Medical Sciences and Peking Union Medical College

Headquarters: Beijing, China
Year Founded: 1956
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Dec 20, 2024
Editor's Commentary

Don’t sleep on China’s academic innovation: a Perspective

Forget the ‘fast follower’ narrative: Plenty of new target biology is now coming from Chinese university labs
BioCentury | Dec 16, 2024
Distillery Therapeutics

Increasing lung MFSD7C levels for hemolytic anemia

BioCentury | Nov 6, 2024
Distillery Therapeutics

Inhibiting NOGO for hypercholesterolemia

BioCentury | May 31, 2024
Distillery Therapeutics

Targeting a GLP-1R-agmatine axis for PCOS

BioCentury | Mar 26, 2024
Distillery Therapeutics

Inhibiting miR-28 axis for MASH

BioCentury | Mar 6, 2024
Discovery & Translation

Distillery spotlight: new Type II diabetes mechanisms from academia

New targets to drive insulin secretion, islet cell numbers and receptor localization from BioCentury’s survey of the 2023 translational literature
BioCentury | Dec 4, 2023
Distillery Therapeutics

Inhibiting ZFYVE28 for insulin resistance

BioCentury | Oct 12, 2023
Distillery Therapeutics

Targeting SCARB2 for hepatocellular carcinoma

Items per page:
1 - 10 of 35